Farmacia e farmacoloxía
Servizo
![Foto de Farmacia e farmacoloxía](/img/noimage.png)
![Foto de Hospital Universitari Germans Trias i Pujol](/img/noimage_org.png)
Hospital Universitari Germans Trias i Pujol
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitari Germans Trias i Pujol (15)
2023
-
A Randomized Trial of Dolutegravir Plus Darunavir/ Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes
Open Forum Infectious Diseases, Vol. 10, Núm. 11
-
Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study
Frontiers in Cellular and Infection Microbiology, Vol. 13
-
Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1
Journal of Infectious Diseases
-
The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain
Frontiers in Public Health, Vol. 11
2022
-
Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 22, Núm. 6, pp. 941-953
-
Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation
Acta Dermato-Venereologica, Vol. 102
2021
-
Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study
Infectious Diseases and Therapy, Vol. 10, Núm. 1, pp. 347-362
2020
-
Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping
Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 12, pp. 3517-3524
2019
-
Overdose of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in an HIV-1-infected subject with attempted suicide
Infection, Vol. 47, Núm. 1, pp. 115-119
2018
-
Cure of chronic hepatitis C virus infection in an HIV-coinfected patient with multiple comorbidities and drug interaction challenges
International Journal of STD and AIDS, Vol. 29, Núm. 9, pp. 933-936
-
Determining the Value of Two Biologic Drugs for Chronic Inflammatory Skin Diseases: Results of a Multi-Criteria Decision Analysis
BioDrugs, Vol. 32, Núm. 3, pp. 281-291
-
Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors
AIDS, Vol. 32, Núm. 1, pp. 121-125
2017
-
Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in HIV-infected Patients: Efficacy, Safety and Tolerance
Basic and Clinical Pharmacology and Toxicology, Vol. 121, Núm. 5, pp. 442-446
2016
-
Consumption of systemic antifungal agents among acute care hospitals in Catalonia (Spain), 2008-2013
Expert Review of Anti-Infective Therapy, Vol. 14, Núm. 1, pp. 137-144
-
Immune reconstitution inflammatory syndrome in an HIV-infected patient using subcutaneous silicone fillers
AIDS, Vol. 30, Núm. 16, pp. 2561-2563